Vocal biomarkers correlate with FEV1 variations during methacholine challenge
Clinical and Translational Allergy · 2025-04 · 15 (4)
DOI: 10.1002/clt2.70055 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Allergy, online erschienen am 28.03.2025. Verfasst von Giovanni Paoletti und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Voicemed s.à.r.l..
Abstract (Originalsprache)
Background
Mobile health applications are increasingly valued for their role in asthma management and the opportunity for large dataset collection. Our study aimed to investigate the feasibility of applying signal‐processing and machine‐learning technologies to detect alterations in the lower airway caliber and develop a machine‐learning algorithm to identify changes in vocal biomarkers and detect bronchoconstriction in patients with airway hyperreactivity.
Methods
This is an explorative observational prospective longitudinal study focused on vocal biomarkers and their association with bronchial constriction and respiratory function. Non‐smoker adults with clinical suspicion of asthma were consecutively enrolled from May 2023 to September 2023. At each step of a Methacholine Challenge Test (MCT) performed on these patients, the respiratory sounds were recorded via a smartphone through an app specifically developed. Several biomarkers were extracted and their relationship with the change in Forced Expiratory Volume in the first second (FEV1) was measured.
Results
Forty‐two subjects were enrolled. The highest correlation with FEV1 came from exhalation vocal events. No single feature exhibited robust behavior across different subjects, while each subject showed “personal” highly correlated features. All values were strongly statistically significant irrespectively of the result of MCT.
Conclusion
The app’s algorithm is sensitive in correlating specific vocal biomarkers to FEV1 variations during MCT. This feature may assist physicians in diagnosing asthma and its exacerbation and in assessing therapy response and adherence. The socio‐economic implications might be significant, and the simplicity of use makes it an ideal tool for research.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
- Personalized Medicine, Asthma and Allergy, IRCCS Humanitas Research Hospital, Rozzano, Italy.
- VoiceMed s.à.r.l., Strassen, Luxembourg.
- Artificial Intelligence Center, IRCCS Humanitas Research Hospital, Rozzano, Italy.
ORCID-Profile: Giovanni Paoletti, Enrico Heffler
Förderung
- Voicemed s.à.r.l.
Zitieren
APA
Paoletti, G., Costanzo, G., Merigo, M., Puggioni, F., Ferri, S., Messina, M. R., Cordella, F., Ranieri, G., Arienzo, A., Savevski, V., Canonica, G. W., de Brito Martins, A., & Heffler, E. (2025). Vocal biomarkers correlate with FEV1 variations during methacholine challenge. Clinical and Translational Allergy, 15(4). https://doi.org/10.1002/clt2.70055
Vancouver
Paoletti G, Costanzo G, Merigo M, Puggioni F, Ferri S, Messina MR, et al. Vocal biomarkers correlate with FEV1 variations during methacholine challenge. Clinical and Translational Allergy. 2025;15(4). doi:10.1002/clt2.70055
BibTeX
@article{Paoletti2025,
author = {Paoletti, Giovanni and Costanzo, Giovanni and Merigo, Morena and Puggioni, Francesca and Ferri, Sebastian and Messina, Maria Rita and Cordella, Fulvio and Ranieri, Giuseppe and Arienzo, Arianna and Savevski, Victor and Canonica, Giorgio Walter and de Brito Martins, Ayana and Heffler, Enrico},
title = {Vocal biomarkers correlate with FEV1 variations during methacholine challenge},
journal = {Clinical and Translational Allergy},
year = {2025},
volume = {15},
number = {4},
doi = {10.1002/clt2.70055}
}
EUVIMED